The firm is an Asia-based venture capital investor focused on early-stage healthcare and life sciences companies. The firm manages multiple healthcare-focused investment funds and primarily invests from company formation and Seed through Series A and other early venture financing rounds. The firm can lead investments or participate alongside other institutional investors and takes a hands-on approach to building and supporting emerging healthcare businesses. The firm invests globally, with a particular emphasis on companies in their region and the United States and opportunities connecting the two life sciences ecosystems.
The firm invests across therapeutics, medical devices, diagnostics, digital health, and healthcare services, with a strong emphasis on innovative therapeutic platforms and drug discovery technologies. Within therapeutics, the firm is broadly agnostic across modalities and indications, prioritizing differentiated science addressing significant unmet medical needs. The firm is comfortable investing at the earliest stages of development, including platform technologies at proof-of-concept stage. For asset-focused therapeutic opportunities, the firm generally seeks sufficient preclinical validation to support the underlying scientific hypothesis. The firm also evaluates innovative medical technologies, molecular diagnostics, and technology-enabled healthcare solutions with strong commercial potential.
From a company and management team perspective, the firm seeks entrepreneurs and scientific founders developing differentiated healthcare technologies with strong scientific foundations and significant market opportunities. The firm actively supports portfolio companies through R&D and business strategy, management recruitment, investor syndication, strategic partnerships, and business development. The firm leverages relationships with pharmaceutical companies, academic institutions, healthcare organizations, and institutional investors to facilitate company growth and cross-border expansion. The firm can serve as a lead investor or co-investor and may seek board representation where appropriate.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
